Medicare Enrolled
Dr. Andrew Brobbey, MD
Internal Medicine · Euclid, OH
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Brobbey from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Brobbey?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Brobbey
Dr. Andrew Brobbey is an internal medicine specialist in Euclid, OH, with 20 years of NPI registration. Based on federal Medicare data, Dr. Brobbey performed 2,060 Medicare services across 1,096 unique beneficiaries.
Between the years covered by Open Payments, Dr. Brobbey received a total of $6,549 from 57 pharmaceutical and/or device companies across 467 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Brobbey is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 9% volume in OH
$6,549 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,060
Medicare services
Top 9% in OH for internal medicine
1,096
Unique beneficiaries
$74
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~103 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
634 | $62 | $104 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
340 | $58 | $139 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
324 | $93 | $160 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
181 | $133 | $291 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
155 | $89 | $197 |
| Hospital discharge day management, 30 minutes or less This service covers the final day of hospital care when the patient is being discharged. It includes coordination of care and instructions for the patient within a time frame of 30 minutes or less. |
124 | $63 | $145 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
50 | $125 | $148 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
39 | $10 | $30 |
| Hospital discharge management, 30+ min This service covers the care provided by a physician or qualified healthcare professional on the day a patient is discharged from the hospital. It requires more than 30 minutes of total time spent on the day of discharge. |
32 | $90 | $160 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
28 | $64 | $115 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
27 | $7 | $7 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
23 | $25 | $26 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
22 | $98 | $199 |
| Nursing facility visit, moderate complexity A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves moderate medical decision making and takes at least 30 minutes. |
20 | $83 | $128 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
17 | $3 | $14 |
| Home health plan of care certification Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians. |
16 | $40 | $70 |
| Flu vaccine, quadrivalent A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection. |
15 | $76 | $78 |
| Urine microalbumin test (kidney screening) A laboratory test that measures the amount of microalbumin, a small protein, in a urine sample. This test is used to detect early signs of kidney damage. |
13 | $6 | $8 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$6,549
Total received (2018-2024)
Avg $936/year across 7 years
Top 12% in OH for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
57
Companies
467
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,549 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$311
2023
$361
2022
$462
2021
$878
2020
$1,133
2019
$1,747
2018
$1,657
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Stryker Corporation
$150
Medtronic, Inc.
$62
Dexcom, Inc.
$38
Exact Sciences Corporation
$25
AstraZeneca Pharmaceuticals LP
$20
Novo Nordisk Inc
$17
Top 3 companies account for 80.3% of 2024 payments
All-time payments by company (2018-2024) ›
PFIZER INC.
$1,285
Novo Nordisk Inc
$677
AstraZeneca Pharmaceuticals LP
$561
Novartis Pharmaceuticals Corporation
$465
SANOFI-AVENTIS U.S. LLC
$369
AbbVie Inc.
$307
GlaxoSmithKline, LLC.
$261
Lilly USA, LLC
$211
Allergan Inc.
$167
Sunovion Pharmaceuticals Inc.
$155
Stryker Corporation
$150
Inspire Medical Systems, Inc.
$141
ABBVIE INC.
$127
Allergan, Inc.
$123
Janssen Pharmaceuticals, Inc
$106
Boehringer Ingelheim Pharmaceuticals, Inc.
$102
AbbVie, Inc.
$96
VIVUS, Inc.
$83
Amarin Pharma Inc.
$77
Astellas Pharma US Inc
$69
Otsuka America Pharmaceutical, Inc.
$64
Takeda Pharmaceuticals U.S.A., Inc.
$63
Medtronic, Inc.
$62
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$60
Teva Pharmaceuticals USA, Inc.
$58
Dexcom, Inc.
$54
E.R. Squibb & Sons, L.L.C.
$53
Greer Laboratories, Inc.
$46
Ironwood Pharmaceuticals, Inc
$37
Purdue Pharma L.P.
$36
Evoke Pharma, Inc.
$32
Scilex Pharmaceuticals Inc.
$32
Avanir Pharmaceuticals, Inc.
$31
Lundbeck LLC
$30
Merck Sharp & Dohme Corporation
$29
Exact Sciences Corporation
$25
Shire North American Group Inc
$19
Eisai Inc.
$19
Paratek Pharmaceuticals, Inc.
$18
Biohaven Pharmaceuticals, Inc.
$17
Philips Electronics North America Corporation
$17
Ultragenyx Pharmaceutical Inc.
$16
QIAGEN, LLC
$16
ITI, Inc.
$16
Merck Sharp & Dohme LLC
$15
Mylan Specialty L.P.
$14
IRONWOOD PHARMACEUTICALS, INC
$14
MannKind Corporation
$14
Abbott Laboratories
$14
UCB, Inc.
$13
Mannkind Corporation
$13
Melinta Therapeutics, Inc.
$13
Kowa Pharmaceuticals America, Inc.
$12
Circassia Pharmaceuticals Inc
$12
Horizon Pharma plc
$12
Collegium Pharmaceutical, Inc.
$11
Braemar Manufacturing, LLC
$11
Top 3 companies account for 38.5% of all-time payments
Associated products mentioned in payments ›
ACTISHIELD · AFREZZA · AJOVY · ANORO · AREXVY · AirDuo Digihaler · Amitiza · BAQSIMI · BASAGLAR · BELSOMRA · BEVESPI AEROSPHERE · BREO · BREZTRI · BYSTOLIC · BYVALSON · Baxdela · Briviact · CAPLYTA · CHANTIX · COLOGUARD · COLOGUARD DNA CAPTURE REAGENTS · Cardiac Monitoring Suite · Cologuard Collection Kit · Creon · Dayvigo · Dexcom G6 Transmitter · ELIQUIS · EMGALITY · ENTRESTO · EUCRISA · FARXIGA · FREESTYLE LIBRE 2 · GATTEX · GIMOTI · HUMALOG · IN.PACT ADMIRAL · INVOKANA · Inspire Upper Airway Stimulation System · KRYSTEXXA · LINZESS · LOKELMA · LONHALA MAGNAIR · LYRICA · Linzess · Livalo · MYRBETRIQ · NORTHERA · NUCALA · NUEDEXTA · NURTEC ODT · NUZYRA · ORALAIR · Ozempic · PANCREAZE · PREMARIN · QUANTIFERON-TB GOLD · QULIPTA · REXULTI · Rybelsus · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · SPIRIVA RESPIMAT · SYMPROIC · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRULICITY · TUDORZA PRESSAIR · Tresiba · Trintellix · UBRELVY · Utibron · VERQUVO · VESICARE · VIAGRA · VRAYLAR · Vascepa · Victoza · Wegovy · XARELTO · XIFAXAN · XTAMPZA · Yupelri · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Internal medicine physicians within 10 mi
1,070
Per 100K population
85.6
County median income
$62,823
Nearest hospital
EUCLID HOSPITAL
2.9 mi
2.9 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Brobbey is a clinical cardiology specialist, with above-average Medicare volume (top 9% in OH), with low-engagement industry engagement in the top 12% of OH peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Brobbey experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Brobbey performed 634 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Brobbey receive payments from pharmaceutical companies?
Yes. Dr. Brobbey received a total of $6,549 from 57 companies across 467 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Brobbey's costs compare to other internal medicine physicians in Euclid?
Dr. Brobbey's average Medicare payment per service is $74. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Brobbey) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Euclid
Browse internal medicine physicians in Euclid ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in OH
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in OH
Which OH internal medicine physicians receive the most from drug and device companies.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology